期刊文献+

老年患者慢性阻塞性肺疾病的防治 被引量:1

Prevention and treatment of chronic obstructive pulmonary disease in elderly patients
下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)是呼吸系统疾病中的常见疾病和多发病,其病死率居所有死因的第4位,且有逐年增加之势。在我国COPD位居主要致死原因的第3~4位,发病率呈逐年上升势态。老年患者占了慢性阻塞性肺疾病患者的很大比例,治疗难度大,死亡率高。早期发现、早期预防、规范化治疗可减少COPD急性加重频率。 Chronic obstructive pulmonary disease (COPD) is one of the most common and frequently-occurring respiratory disease, the mortality rate of which ranked the 4th of all causes of death and there is a trend of increasing year by year. COPD is one of the major causes of disease death in China which ranked third--fourth, and the incidence rate shows an increasing trend. Elderly patients account for a large proportion in COPD patients, and the treatment is difficult with high mortality rate. Early diagnosis, early prevention, and standardized treatment can reduce the frequency of exacerbation and improve the prognosis as well.
出处 《中华老年多器官疾病杂志》 2012年第6期401-404,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 老年人 慢性阻塞性肺疾病 防治 aged chronic obstructive pulmonary disease treating and preventing
  • 相关文献

参考文献7

  • 1全国COPD流行病学调查研究课题组.我国慢性阻塞性肺疾病发病的主要危险因素研究[C].中华医学会第七次呼吸病学术会议暨学习班论文汇编.2006.
  • 2Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease (Revised 2011)[EB/OL]. http://www.goldcopd.org/guidelines-global-strategy-for-diag nosis-management.html.
  • 3Tashkin DP, Celli B, Serm S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(15): 1543-1554.
  • 4Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD[J]. N Engl J Med, 2011, 364(12): 1093-1103.
  • 5CeUi BR, Thomas NE, Anderson JA. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study[J]. Am J Respir Crit Care Med, 2008, 178(4): 332-338.
  • 6Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study[J]. Lancet, 2008, 371(9629): 2013-2018.
  • 7Pinner NA, Hamilton LA, Hughes A. Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease[J]. Clin Ther, 2012, 34(1): 56-66.

共引文献2

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部